Publications by Prof. Foday Sahr

1. Johnson O, Bawoh M, Begg K, Bell N, Jalloh B M, Gbao D, N’Jai A, Sahr F, Samai M, Kelly A. H, & Sevdalis N, (2023) Designing a leadership and management training curriculum for undergraduate health professions students: Lessons from the University of Sierra Leone, Global Public Health, 18:1 (2023).

2. Yendewa G A, Wang G M, James P B, Massaquoi S P E, Yendewa S A, Sahr F. Prevalence of Chronic Hepatitis B Birus Infection in Sierra Leone, 1997-2022: A Systematic Review and Meta-Analysis.  The American Journal of Tropical Medicine and Hygiene (2023) 1 (aop)

3. Ghazzawi M, Yendewa S A, James P B, Massaquoi S P, B, Babawo L S, Sahr F. Assessment of knowledge, stigmatizing attitudes, and health-seeking behaviors regarding hepatitis B virus infection in a pharmacy and community setting in Sierra Leone: a cross… Healthcare (2023) 11 (2), 177

4. Yendewa G A, James P B, Mohareb A M, Barrie U, Massaquoi, Sahr F. Childhood Hepatitis B Immunization Coverage and Barriers in Sierra Leone, Liberia, and Guinea: Analysis of national Surveys (2018-2020).  medRxiv, (2023).

5. Yendewa G A, Jiba D F, Barrie U, Yendewa S A, Deen G F, Sahr F. Hypertension Among Adults with HIV initiating Antiretroviral Therapy in Freetown, Sierra Leone: A Cross-sectional Study.  medRxiv, (2023).

6. Cummings P E, Wang G M, Ja,es P B, Massaquoi SP, Yendewa S A, Sahr F. Hypertension COVID-19 Vaccine Uptake and Hesitancy among People with HIV in Freetown, Siera Leone: Across-sectional Study.  medRxiv, (2023)

7. Yendewa G A, Wang G M, James P B, Massaquoi SP, Yendewa S A, Sahr F. Prevalence and Burden of Chronic Hepatitis B Virus Infection in Sierra Leone, 1997-2022: A Systematic Review and Meta-Analysis. medRxiv, (2022).

8. Johnson O, Sahr F, Sevdalis N, Kelly A H. Exit, Voice or neglect: Understanding the choices faced by doctors experiencing barriers to leading health system change through the case of Sierra Leone. SSM Qualitative Research in Health, (2023) 2 (2022)

9. Yendewa S A., Ghazzawi M, James A P, Smith M., Massaquoi S P., Babawo L S., Deen, G. F., Russell J.B.W., Samai M., Sahr F., Lakoh S.,  Salata R.A., Yendewa G.A. COVID-19 Vaccine Hesitancy Among Healthcare Workers and Trainees in Freetown, Sierra  Leone: A Cross-Sectional Study.  Vaccines (2022).

10. Lin L., Zhang J., Rogers J., Campbell A., Zhao J., Harding D., Sahr F., Liu Y., and Wurie I. The Dynamic change of SARS-CoV-2 variants in Sierra Leone. Infection, Genetics and Evolution (2022) 

11. Lakoh S, Yi L, Sevalie S, Guo X, Adakanmbi O, Smalle I O, Williams N, Sahr F. Incidence and risk factors of surgical site infections and related antibiotic resistance in Freetown, Sierra Leone: A prospective cohort study.  Antimicrobial Resistance and Infection Control (2022) 11 (1), 1-12. 

12. Kamara R F, Saunders M J, Sahr F, Losa-Garcia J E, Foday L, Davies G. Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort study.  The Lancet Global Health (2022) 10 (4)

13. Yendewa G A, Lakoh S, Jiba D F, Yendewa S A, Barrie U, Deen G F, Sahr F. Hepatitis B virus and tuberculosis and associated with increased noncommunicable disease risk among treatment-Naïve people with HIV: opportunity for prevention, early. Journal of Clinical Medicine (2022) 11 (12), 3466.

14. Lakoh S, Kanu S K, Conteh S K, Russell J B W, Sevalie S, Williams C E E, Sahr F. High levels of surgical antibiotic prophylaxis: Implications for hospital-based antibiotic stewardship in Sierra Leone.  Antimicrobial Stewardship and Health care Epidemiology (2022) 2 (1), e111.

15. Kanbgai J B, Heumann C, Hoelscher M, Sahr F, Froeschi G. Factors associated with length of stay and treatment outcome of Ebola treatment center in Sierra Leone during the peak period of the West African Ebola Epidemic.  Archives of Public Health (2021) 79,1-14.

16. Johnson, O.; Sahr, F.; Begg, K.; Sevdalis, N. and Kelly, A. H. To bend without breaking: a qualitative study on leadership by doctors in Sierra Leone. Health Policy and Planning 00, (2021) 1-15.

17. Zhao G, Chen H, Yan Y, Jiang J, Lin L, Jiang B, Shar F, Sevalie Q Xu. The Establishment and Application of Mobile Electronic Surveillance System of Infectious Diseases with the Help of China – Sierra Leone, 2016-Present.  China CDC weekly (2021) 3 (36), 763.

18. Kamara R F, Carlos J E, Sahr F, Foray L, Saunders M J, Wingfield T E. Predictors of adverse treatment outcomes among people with drugs-resistant tuberculosis in Sierra Leone: a National, Retrospective Cohot Study. Thorax (2021) 76 (suppl 1), A52-A53.

19. Yendewa, G A, Lakoh S, Yendewa S A, Bangura K., Tabernilla A., Patino L., Jiba D F., Massaquoi S.P., Osario N S., Deen G P., Sahr F., Salata R A., and Poveda E. Characterizing HIV1 genetic subtypes and drug resistance mutation among children, adolescents, and pregnant women in Sierra Leone. GENES (2021).

20. Lavine A., Logan, A., Perera S., Yam D., Garbar S., Kennedy S B., Liu T., Aluisio A., Massaquoi A and Sahr F. Association between oral antimalarial medication administration and mortality among patients with EBOLA Virus Disease: A multisite cohort study. BMC Infectious Diseases October 2021.

21. Kangbai J B., Sheku M., Koroma B., Macathy J M., Kaitibi D., Sahr F., George A M., Gegbe F., Cummings-Wray D., and Babawo L S. Africa’s COVID-19 third wave: A coup behavior-disease system in a mutual feedback loop. G Med Sci. 2021:2(5).

22. Kangbai, J. B., Babawo, L. S., Kaitibi, D., Sandy, A. A, George, A. M. and Sahr F. Re-reading A C T, BCG and low COVID-19 in Africa. Comprehensive Clinical Medicine. (2021).

23. Adaken, C., Scott, J., Sharman, R.,…. Sahr F., the Ebola-CP Consortium, Dimolow, R. J., Tedder, R. S., Semple, M. G., Paxton, W. A. and Pollakis, G. Ebola Virus antibody decay-stimulation is a high proportion of survivors. (2021).

24. Bangura, U., Buanie, J., Lamin, J., Davis, C., Bongo, G, N., Dawson, M., Ansumana, R., Sondufu, D., Thomson, E. C., Sahr F, and Fichet-Calvet, E., Lassa Fever circulation in small mammal population in Bo District, Sierra Leone.  (2021). Vol.10 No. 28

25. Lakoh S, Jiba D F, Vandy A O, Pveda E, Adekanmbi O, Murray M J S, Sahr F. Assessing eligibility for differentiated service delivery, HIV-infected patients in Sierra Leone: a pre-implementation.  Global health action (2021) 14 (1), 1947566.

26. Lakoh S, Jiba D F, Adekanmbi O, Poveda E, Sahr F, Deen G F, Foray L M. Diagnosis and treatment outcomes of adult tuberculosis in an urban setting with high HIV prevalence in Sierra Leone: A cross…  International Journal of Infectious Diseases (2020) 96, 112-116.

27. Scott J, Sharma R, Meredith L, Dunning J, Moore C, Sahr F, Ward S. Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean subjects.  Access Microbiology (2020) 2 (2). 212.

28. Yam, D, Aluisio, A. R; Perera, S. M.; Peters, J. L.; Cho, D. K.; Kennedy. S. B.; Massaquoi, M.; Sahr, F.; Smit. M. A.; Mocks, L.; Liu, T. and Levine, A. C. Association between multivitamin supplementation and motility among patients with Ebola Virus disease: An International multisite cohort study.  African journal of Emergency, medicine. Available online (2020).

29. Kangbai J. B, Heumann C, Hoelscher M, Sahr F, Froeschl G., Severity Score for Predicting in-facility Ebola treatment outcome, Annals of Epidemiology. (2020).

30. Yam D, Aluisio A R, Perere S M, Peters J L, Cho D K, Kennedy S B, Sahr F. Emergency Medical Service (2020)32, 177-84.

31. Scott J. T, Sharma R., Meredith L. W., Dunning J., Moore C. E., Sahr F., Ward S. A., Goodfollow P. H., Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients. EBioMedicine (Jan. 2020).

32. Aluisio A. R., Perera S. M, Yam D, Garnern S., Peters J. L., Abel L., Cho D. K., Woldemichael D., Kennedy S. B., Massaquoi M., Sahr F., Liu T., Levine A. S., Association between treatment with oral third-generation cephalosporin antibiotics and mortality outcomes in in Ebola virus disease: a multinational retrospective cohort study.  Tropical Medicine and International health (2020).

33. Aluisio AR, Yam D ,   Peters J. L,  Daniel K,  ChoL,  Kennedy  Massaquoi M,  Sahr F,  Smit M. A, Liu T,. The Impact of Intravenous Fluid Therapy on Survival Among Patients with Ebola Virus Disease: An International Multisite Retrospective Cohort Study. The Impact of Intravenous fluid therapy on survival among patients with Ebola virus disease:  An International multisite retrospective cohort study. Clinical Infectious Diseases (2020).

34. Steptoe P J, Momorie F, Fornah A D, Komba P, Emsley E, Scott J T, Sahr F. Evolving longitudinal retina observations in a cohort of survivors of Ebola virus disease.  JAMA ophthalmology (2020) 138 (4), 395-403.

35. Sample C, Scott J, Sesay F, Massaquoi T, Idriss B, Sahr F, Sample M G. Characterizing Post Ebola Syndrome: initial observations and future research agenda.  Emerging Infectious Diseases, (2020).

36. Hannigan B, Whitworth J, Carroll M, Roberts A, Bruce C, Samba T, Sahr F. The Ministry of health and Sanitation, Sierra Leone-Public Health England (MOHS_PHE) Ebola biobank.  Wellcome Open Research (2019) 4

37. Scott J T, Sharma R, Meredith L W, Dunning J, Moore C E, Sahr F, Ward S. Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean patients.  American Journal of Tropical Medicine and Hygiene (2019) 101 (5_supp1).

38. Kangbai J B, Heumann C, Hoelscher M, Sahr F, Froeschl G. Sociodemographic and clinical determinants of in-facility case fatality rate for 938 Ebola patients treated in Sierra Leone. (2019)

39. Steptoe P J, Momorie F, Fornah A D, Komba P, Emsley E, Scott J T, Sahr F. Multimodal Imaging and Spatial Analysis of Ebola Virus Retinal Lesions and associated Dark Without Pressure in a Cohort of Fourteen Ebola Survivors.  JAMA Ophthalmology (2019) 136 (6), 689.

40. Aluisio A, Yam D, Peters J L, Cho D K, Perera S M, Kennedy S B, Sahr F. Association Between Vitamin A Supplementation and Mortality Among Patients with Ebola Virus Disease: An International Multisite Cohort Study.  Prehospital and Disaster Medicine (2019) 34.

41. Hogan K M, Jiang J F, Bangura H S, Sevalie S, Song Y J, Sun Y, Li J, Sahr F. Impact of Ebola Outbreak on TB treatment adherence and outcomes in Sierra Leone.  American Journal of Tropical Medicine and Hygiene (2019).

42. Coates E, Hannigan B, Whitworth J, Carroll M, Roberts A, Bruce C, Sahr F. The Ministry of Health and Sanitation, Sierra Leone-Public Health England (MoHS-PHE) Ebola Biobank.Wellcome Open Research (2019) 4, 115.

43. Halfmann P., Eisfeld A. J., Watanabe T., Maemura T., Yamashita M., Fukuyama S., Armbrust T., Rozich I., N’jai A. U., Neumann G., Yoshihiro K., Sahr F., Serological analysis of Ebola virus survivors and close contacts in Sierra Leone:  A cross-sectional study. PLOS Neglected Tropical Disease (2019).

44. Nagel E, Blackowicz M J, Sahr, F, Jarrett O D. Impact of the Ebola epidemic on clinical outcomes of HIV-infected soldiers and their dependents in Sierra Leone.  International Journal of STD and AIDS (2019) 30 (2), 106-112.

45. Lakoh S., Jiba D. F., Kanu J. E., Poveda E., Salgado-Barreira A., Sahr F., Sesay M., Deen G. F. Sesay T., Gashau W., Salata R. A., Yendewa G. A., Courses of hospitalization and predicators of HIV-associated morality at the main referral hospital in Sierra Leone a prospective study.  BMC Public Health. (2019).

46. Aluisio A. R., Perera S. M., Yam D., Stephanie G., Peters J. L., Abel L., Cho D. K., Kennedy S. B., Massaquoi M., Sahr F., Brinkmann S., Locks L. M., Liu T., Levine A. C., Vitamin a supplementation was associated with reduced mortality in patients with Ebola Virus disease during the West African outbreak. Journal of Nutrition (2019).

47. Hannigan B., Whitworth J. A. G., Carrol M. W., Roberts A. D. G., Bruce C., Samba T., Sahr F., Coates Elizabeth. The Ministry of Health and Sanitation – Public Health England (MOHS-PHE) Ebola Biobank. (2019).

48. Yendewa G. A., Sahr F., Lakoh S., Ruiz M., Patrino L., Tabernilla A., Deen G. F., Sesay M., Salata R. A., Poveda E,. Prevalence of drug resistance mutations among ART-naïve and experienced HIV-infected patients in Sierra Leone. (2019).

49. Kyle J. E., Burnum-Johnson K. E., Wendler J. P., Eisfeld A. J., Halfmann P., Watanabe T., Sahr F., Smith R. D., Kawaoka Y., Waters K. M., Metz T.O., Plasma lipidome reveals critical illness and recovery from human Ebola virus disease. Proceedings of the National Academy of Science (2019).

50. Liu W. J., Sesay F. R., Courier A., Knust B., Marrinan J. E., Whitmer S.L.M., McDonald S.L.R., Gaillard P., Liu Y., Su Q., Zhang Y., Crozier I., Ariyarajah A., Carino M., Sahr F…….. Deen G. F., Comprehensive Clinical and Laboratory Follow-up of a female patient with Ebola Virus Disease: Sierra Leone Ebola Virus Persistence Study. Open Forum Infectious Diseases. (2019).

51. Kangbai J. B., Heumann C., Hoelscher M., Sahr F., Froeschi G., Epidemiological characteristics, clinical manifestations, and treatment outcome of 139 paediatric Ebola patients treated at a Sierra Leone Ebola treatment center. BMC infectious Diseases (2019).

52. Peters J. L., Cho D. K., Aluisio A. R., Kennedy S. B., Massaquoi M., Sahr F., Perera S. M.. Environmental temperature and case fatality of patients with Ebola virus disease in Sierra Leone and Liberia, 2014 / 2015: a retrospective cohort study.  (2019).

53. Garbern S. C, Yam D, Aluisio A. R, Cho D, K, Kennedy S. B, Massaquoi M, Sahr F, Perera S. M, Levine A. C, Liu T.  Effect of Mass Artesunate – Amodiaquine Distribution on Mortality of Patients with Ebola Virus Disease during West African Outbreak.  Open Forum Infectious Diseases, of 250. (2019).

54. Kangbai J. B, Heumann C, Hoelscher M, Sahr F, Froeschl G., Sociodemographic and clinical determinants of in facility case fatality rate for 938 adult Ebola patients treated at Sierra Leone Ebola treatment center. Social Sciences Research Network (2019)

55. Yendewa GA, Sahr F, Aguilera A, Lakoh S, Sesay M, Deen GF, Patiño L, Poveda E, Salata RA. Seroprevalence of Hepatitis B, Hepatitis and Human T-cell lymphostropic Virus Infections. HIV – infected patients in Sierra Leone. Am J Trop Med Hyg. (2019).

56. Rasche A, Lehmann F, König A, Goldmann N, Corman VM, Moreira-Soto A, Geipel A, van Riel D, Vakulenko YA, Sander AL, Niekamp H, Kepper R, Schlegel M, Akoua-Koffi C, Souza BFCD, Sahr F, Olayemi A, Schulze V, Petraityte-Burneikiene R, Kazaks A, Lowjaga KAAT, Geyer J, Kuiken T, Drosten C, Lukashev AN, Fichet-Calvet E, Ulrich RG, Glebe D, Drexler JF. Highly diversified shrew hepatitis B viruses corroborate ancient origins and divergent infection patterns of mammalian hepadnaviruses.  Proc Natl Acad Sci U S A.

57. Lakoh S, Jiba D R, Kanu J E, Poveda E, Salgado-Barreira A, Sahr F. Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study.  BMC Public Health (2019) (1), 1-9.

58. Aluisio A R, Yam D, Peters J L, Cho D K, Perera S M, Kennedy S B, Sahr F. Treatment with intravenous fluid therapy was not associated with improved survival among patients with Ebola Virus Disease: An International Multisite Cohort Study.  Annals of Emergency Medicine (2018) 72 (4).

59. Steptoe P. J., Momorie F., Fornah A. D., Komba S. P., Emsley E., Scott J. T., Harding S. P., Vandy M. J., Sahr F., Beare N. A. V., Semple M. G. Multimodal Imaging and Spatial Analysis of Ebola Retinal Lesions in 14 Survivors of Ebola Virus Disease. JAMA Ophthalmology (2018).

60. Qin Y., Bangura H.S., Li B., Zhou Y., Yuan Y., Sun Y., Li J., Zhao Z., Jiao J., Song B., Sevalie S., Jiang T., Sahr F., Jiang J., Self-reported knowledge and practices of healthcare workers on occupational exposure and protection from infectious Disease at the Military Hospital in Sierra Leone.  The Journal of Medical Research (2018).

61. Masssquoi T.A, Buurka R.M,Yaug G., Lakoh S.,Stephen S., LI Bo, Jia H, Huang L, Deen G.F, Beynon F, Sahr F. Cross sectional study of chronic hepatitis B prevalence among healthcare workers in an urban   setting, Sierra Leone PLOSONE (2018).

62. Peters J L, Cho D.K, Aluisio AR, Kenndy S.B/ Massaquoi M.B.F, Sahr F, Perera S.M and Levine A.C. Environmental Temperature and case fatality and persons with Ebola virus Disease in Sierra Leone and Liberia 2014- 2015 Tropical Medicine on International Health (2018).

63. Yendewa A, Poveda E. Yendewa S.A, Sahr F, Quiñones-Mateu M.E and Salata R.A. HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic.  AIDS Rev. (2018)

64. Bonwitt J, Dawson M, Kandeh M, Ansumana R, Sahr F, Brown H, Kelly A.H. Unintended Consequences of the ‘bushmeat ban’ in West Africa during the 2013–2016 Ebola virus disease epidemic. Social Science & Medicine 200 (2018) 166–173.

65. Whitmer S.L.M, Ladner J.T, Wiley M.R, ……Sahr F, et al. Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors. Whitmer et al., 2018, Cell Reports 22, 1159–1168 (2018).   

66. Fitzgerald F, Naveed A, Wing K, Gbessay M, Ross JC, Checchi F, Youkee D, Jalloh B, Baion D, Mustapha A, Jah H, Lako S, Oza S, Boufkhed S, Feury R, Bielicki JA, Gibb  M, Klein N, Sahr F, Yeung S. Development of a Pediatric Ebola Predictive Score, Sierra Leone. Emerging infectious diseases Volume 24, Number 1—(2018)

67. Qin Y L, Li B, Zhou Y S, Zhang X, Li L, Song B, Liu P, Zhao Z P, Sahr F. Prevalence and associated knowledge of hepatitis B infection among healthcare workers in Freetown Sierra Leone.  BMC Infectious Diseases (2018) 18, 1-8.

68. Howlett P J, Walder A R, Lisk D R, Fitzgerald F, Sevalie S, Lado M, N’jai A, Sahr F. Case series of severe neurologic sequelae of Ebola virus disease during epidemic, Sierra Leone. Emerging Infectious Disease (2018) 24 (8), 1412.

69. Smith S J, Kamara A R Y, Sahr F, Samai M, Swaray A S, Menard D….. Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in…. Acta tropical (2018) 185, 363-370.

70. Rojek A M, Dunning J, Leliogdowicz A, Castle L, Lieshout W Van, Sahr Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola virus disease epidemic.  Clinical Infectious Diseases (2018) 66 ( 9).

71. Yendewa G A, Poveda E, Lakoh S, Yendewa S A,Jiba D R, Sahr F. High prevalence of late-stage disease in newly diagnosed human immunodeficiency virus patients in Sierra Leone.  Open Forum Infectious Diseases (2018) 5 (9).

72. Carter R J, Idriss A, Widdowson M A, Samai M, Schrag M, Sahr F. Implementing a multisite clinical trial in the midst of an Ebola outbreak: lessons learned from the Sierra Leone trial to introduce a vaccine against Ebola.  The Journal of Infectious Diseases (2018) 217 (suppl_1)

73. Steptoe P J, Scott J T, Sahr F, Vandy M, Harding S P, Beare N A V. Ophthalmic manifestations and causes of vision impairment in Ebola virus disease survivors in Monrovian, Liberia (Ophthalmology, 2017; 124: 170-177).  Ophthalmology (2018) 125 (3), e19.

74. Fitzgerald F, Wing K, Naveed A, Gbessay M, Ross J C G, Checchi F, Sahr F. Refining the paediatric Ebola case definition: a study of children in Sierra Leone with suspected Ebola virus disease.  The Lancet (2017) 389, S19

75. Steptoe P J, Beare N V, Scott J T, Vandy M J, Harrison-Williams L, Sahr F. Longitudinal Changes of Geographic Retinal Darkening in a Cohort of Ebola Survivors. Investigative Ophthalmology and Visual Science (2017) 58 (8).

76. Steptoe P J, Scott J T, Baxter J M, Parkes C K, Dwivedi R, Czanner G, Sahr F. A Novel Retinal Finding in Ebola Survivors, A Case-Control Study. Emerging infectious Diseases, (2017)

77. Fitzgerald F, Baion D E , Wing K, Yeung S, Sahr, F. The predicament of patients with suspected Ebola.  The Lancet Global Health (2017) 5 (7), e659.

78. Eisfeld A.J. Halfmann P.J, Wendler J.P, N’jai A, Sahr F, Kawaoka Y. Multi-platform ’Omics Analysis of Human Ebola Virus Disease Pathogenesis. Cell Host & Microbe, Volume 22. (2017).

79. Djibo DA, Sahr F, McCutchan JA, et al. Prevalence and Risk Factors for Human Immunodeficiency Virus (HIV) and Syphilis Infections Among Military Personnel in Sierra Leone. Curr HIV Res. (2017);15:128-36. 

80. Deen G F, McDonald S L R, Marrinan J E, Sesay F R, Ervin E, Thorson A E, Xu W, Stroher U, Ongpin P, Abad N, Ariyarajah A, Malik T, Liu H, Ross C, Durski K N, Gaillard P, Morgan O, Formenty P, Knust B, Broutet N, Sahr F, On behalf of the Sierra Leone Ebola Persistence Study Group. Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebola virus disease survivors in Sierra Leone: Methodology and Lessons learned. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0005723 (2017).

81. Jagadesh S, Sevalie S, Fatoma R, Sesay F, Sahr F, Faragher B, Semple M G, Fletcher T E, Weigel R, and Scott J T. Disability among Ebola Survivors and their close contacts in Sierra Leone: A retrospective case-controlled cohort study. Clinical Infectious Diseases, cix705, https://doi.org/10.1093/cid/cix705. (2017).

82. Steptoe P J, Scott J T, Harding S P, Beare N.A.V, Semple M G, Vandy M J, and Sahr F. Ocular complication in Su8rvivors of the Ebola Outbreak in Guinea. American Journal of Ophthalmology. Volume 181, (2017), Page 180.

83. Bonwitt J, Kandeh M, Dawson M, Ansumana R, Sahr F, Kelly AH, et al. Participation of women and children in hunting activities in Sierra Leone and implications for control of zoonotic infections. PLoS Negl Trop Dis 11(7): (2017).

84. Steptoe P J. , Scott J T., Baxter J M., Parkes C K, Dwivedi R,  Czanner G, Vandy M J., Momorie F, Fornah A D, Komba P, Richards J,  Sahr F, Beare N A, and Semple M G. Novel retinal lesion in Ebola survivors, Sierra Leone, 2016. Emerg Infect Dis. 2017.

85. Fitzgerald F, Wing K, Naveed A, Gbessay M, Ross J.C, Checchi F,Youkee D, Jalloh M.B, Baion   D, Mustapha A, Jah H, Lako S, Oza S, Boufkhed S, Feury R, Bielicki J, Williamson E, Gibb,  D.M, Klein, N, Sahr F, Yeung S, Risk in the “Red Zone”: outcomes for children admitted to Ebola holding units in Sierra Leone without Ebola virus disease. Clin Infect Dis, (2017).

86. Sahr F, Massaquoi T A, Idriss B R, Sesay F R, Lamin J M, Baker D S, Nicol S, Conton F B, Johnson G W, Abiri O T,  Kargbo O,  Kamara P, Goba A, Russell J B W, Gevao S M. Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone. Journal of Infection74: (2017). 

87. Sahr, R Ansumana, Massaquoi T A, Idriss B R, Sesay F R, Lamin J M. Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone: Journal of Infection (2017) 74 (3), 302-309

88. Deen G., Broutet N., Xu W., Knust B., Sesay F. R., Sir M., Ervin E., Marrinan J. E., Gaillard P., Habib N., Liu H., Thorson A., Yamba F., Sahr F,; Ebola RNA persistence in semen of Ebola Virus Disease survivors – Final report. The New England Journal of Medicine (2017).

89. Bonwitt J., Kandeh M., Dawson M., Ansumana R., Sahr F., Kelly A. H., Brown H,. Participation of women and children in hunting activities in Sierra Leone and implications for control of zoonotic infections. PLOS Neglected Tropical Diseases (2017)

90. Conton B, Gevao S, Sahr F, Kargbo O, Kamara P, Bah A, Massaquoi M, Idriss M, Sesay F, Williams A, Baker S, Nicol S and Russell J. Do ABO and Rhesus blood groups affected susceptibility to, and prognosis of Ebola virus infection? J VirolAntivir Res (2017), 6:1

91. Arias A, Watson S. J., Asogun D, Tobin E. A., Lu J, Phan M Vm T., Jah U, Wadoum R. E. G., Meredith L, Thorne L Caddy S, Tarawalie A, Langat P, Dudas G,…… Horby P, Dunning J, Sahr F, et al. Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases. Virus Evolution, (2016). 2(1)

92. Fitzgerald F C, Wing K, Naveed A, Gbessay M, Ross, JC G, Checchi F, Sahr F. Comparison of children testing negative and positive for Ebola virus disease in Ebola holding units, Sierra Leone.  Archives of Disease in Childhood, (2016) 101 (supp1 1). A3-A5.

93. Nagel E, Sahr F, Jarrett O. Impact of Ebola on loss to follow-up of HIV-infected soldiers and their dependents in Sierra Leone.  Annals of Global Health, (2016) 82 (3).

94. Fitzgerald F C, Naveed A, wing K, Gbessay M, Ross J C G, Checchi F, Sahr F. Ebola virus disease in Children in Sierra Leone: A retrospective cohort study. Archives of Disease in Childhood, (2016)

95. Bonwitt J, Mari Saez A, Lamine J, Ansumana R., Dawson M, Buanie J, Lamin J, Sondufu D, Borchert M, Sahr F., Fichet-Calvet E., Brown H.,. At Home with Mastomys and Rattus: human – rodent interactions and     potential for primary transmission of Lassa virus in domestic spaces. American Journal of Tropical Medicine & Hygiene, (2016).

96. Ratnayake R, Ho L. S., Ansumana R, Brown H, Borchert M, Miller L, Kratz T., McMahon S. A., Sahr F., Improving Ebola infection prevention and control in primary healthcare facilities in Sierra Leone: a single-group pretest post-test, mixed-methods study. BMJ Global Health. (2016).

97. Fitzgerald, F. ; Wing, K. ; Naveed, A. ; Gbessay, M. ; Ross, J.C. ; Checchi, F. ; Youkee, D. ; Jalloh, M.B. ; Baion, D. ; Mustapha, A. ; Jah, H. ; Lako, S. ; Oza, S. ; Boufkhed, S. ; Feury, R.  ; Bielicki, J.; Williamson, E. ; Gibb, D.M. ; Klein, N. ; Sahr, F. ; Yeung, S. ; G28 Ebola virus disease in children in Sierra Leone: A retrospective cohort study. Archieves of Disease in Childhood (2016)101 (Suppl 1):A19.2-A21.    

98. Bonwitt J., Kelly A. H., Ansumana R., Agbla S.,Sahr F.,  Mari Saez A., Borchert M., Kock R.,  Fichet-Calvet E., Rat-atouille: A Mixed Method Study to Characterize Rodent Hunting and Consumption in the Context of Lassa Fever. EcoHealth, (2016). Volume 13, Issue 2, pp 234–247

99. Fitzgerald F, Naveed A, Wing K, Gbessay M, Ross JC, Checchi F, Youkee D, Jalloh MB, Baion D, Mustapha A, Jah H, Lako S, Oza S, Boufkhed S, Feury R, Bielicki JA, Gibb DM, Klein N, Sahr F, Yeung S. Ebola Virus Disease in Children, Sierra Leone, 2014-2015. Emerg Infect Dis.( 2016) ;22 (10):1769-77.

100. Davey R., Dodd L, Proschan M, Nordwall J, Koopmeiners J, Sahr F., A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N Engl J Med (2016); 375:

101. Dunning J., Sahr F, Rojek A, et al F. G,. Experimental Treatment of Ebola Virus Disease with TKM-130803:  A single-Arm phase2 Clinical Trial.  PLOS,Medicine (2016).

102. Kyobe Bosa H, Orikiiriza J.T, Vairo F, Mubiru F, Bulwadda D, Kamara C.S, and Sahr F: Predictors of paediatric clinical outcomes and associated age-specific mortality in the West African Ebola epidemic 2014-15. A comparative secondary data analysis of two districts in Sierra Leone. International Journal of Infectious Diseases (2016).

103. Scott J. T, Sesay F. R., Massaquoi T, Idriss B. R,. …….. Sahr F and Malcolm G. Sample. Post-Ebola Syndrome, Sierra Leone.  Centers for Disease Control and Prevention:  Emerging Infectious Disease Journal ISSN:  1080-6059, (2016).

104. Fitzgerald F, Naveed A, Wing K, Gbessay M, Ross JC, Checchi F, Youkee D, Jalloh MB, Baion D, Mustapha A, Jah H, Lako S, Oza S, Boufkhed S, …… Sahr F., Feury R, Bielicki JA,  DM, Klein N,. Ebola Virus Disease in Children, Sierra Leone, 2014-2015. Emerg Infect Dis.(2016) (10):1769-77.

105. R Ansumana, J Lamin, ………. F Sahr, A Gbakima. Changing Trends in the Diagnosis of Malaria and Typhoid Fever. Sierra Leone Journal of Biomedical Research (2016):8 (1) 1-3

106. Ratnayake E, Ho L S, Ansumana R, Brown H, Borhchert M, Miller L, Kratez T, Sahr F. Improving Bola infection prevention and control in primary healthcare facilities in Sierra Leone:  a single-group pretest post-test, mixed-methods study.  BMJ Global Health (2016) 1 (4).

107. Nabieu P.F; Gevao P.P; Songu-M’brewa K, Gegbai I.B, Musa M., Swaray A.B Kamara C.D.S., Sahr F. and Kamara T.B. Case Report:  A Grant Unirary Bladder Stone in a female patient.  Sierra Leone Journal of Biomedical Research. Vol. 7. No. 2. (2015)

108. Deen G. F, Knost B, Bruoutet N, Sesay F.R Formenty P. ….. Sahr F. Ebola RNA persistence in semen of Ebola Virus Disease Survivors – Preliminary Report. Eng J. Med, (2015).

109. Brown H, Kelly A. H, Mari-Saez A, Fichet-Calvet E, Gunther S, Magassouba N, Sahr F. and Borchert M. Extending the “Social” Anthropological contributions to the study of viral Haemorrhagic Fevers.  PLOS Neglected Tropical diseases (2015).

110. Deen G F, B Knust, Broutet N, Sesay F R,  Formenty P,  Ross C,  Thorson A E, FSahr F. Ebola RNA persistence in semen of Ebola virus disease survivors.  Eng J. Med. (2015)14.

111. Ansumana R, Jacobson K, Sahr F, Sesay S, Bangura H.S. Jalloh M.B, and Idriss M.R, Ebola in Freetown Area, Sierra Leone – A case study of 558 Patients Eng J. Med. (2014).

112. Sahr F, Smith S.J, Kamara A, Warsame M, Sillah J and Swarray A. Assessment of the Therapeutic Efficacy of Two Artemisinin-Based Combinations in the Treatment of Uncomplicated Falciparum Malaria among Children Under 5 Years in Four District Hospitals in Sierra Leone.  Sierra Leone Journal of Biomedical Research (2013) Vol. 5 (1) pp 4 – 8

113. Ansumana R, Bockarie A.S, Sankoh P, Jacobson K.H, Koroma A.B, Malanoski A.P, Meehan K.A, Leski T, Jimmy D.H, Bangura U, Sahr F, Lin B and Stenger D.A. The Use of Mobile Electronic Devices for Public Health Data Collection and Syndromic Surveillance at the Republic of Sierra Leone Armed Forces.  Sierra Leone Journal of Biomedical Research (2013) Vol. 5 (1) pp 9 – 13

114. Koroma J.B, Sesay S, Sonnie M, Hodges M.H, Sahr F, Zhang Y, Bockarie M.J, Impact of three Rounds of Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone. PLOS Neglected Tropical Diseases.  (2013).  Plosntds/…/journal. Pntd. 0002273.

115. Gevao S.M, Rogers M.H, Sahr F, and Gbakima A.A. Seroprevalence and Assessment of knowledge on HIV/AIDS amongst female commercial sex workers in Freetown, Sierra Leone.  Journal of Pure and Applied Sciences. (2012) Vol. 11 pp 50-54

116. Gbakima A.A, Konteh R, Kramer N, Sahr F, George T.A and Luckay A. Nutritional Status of Children in Displacement Camps in Sierra Leone. Sierra Leone Journal of Biomedical Research (2012) Vol. 4 (1) pp 12-18

117. Sahr F, Gevao S.M, Bockarie A, Ibrahim-Sayo E, Sevalie S, Hanciles A and Gbakima A.A: Prevalence and Intensity of intestinal helminthes and their response to treatment in a rural fishing community in Sierra Leone.  Sierra Leone Journal of Biomedical Research. (2010). Vol. 2 (2). Pp 122-126.

118. Bokarie A, Gbakima A A, Gevao Sahr M, Hanciles A, Ibrahim-Sayo E. Prevalence and intensity of intestinal Helminth Parasites and their response to treatment with Albendazole in Rural Community in Sierra Leone.  Sierra Leone Journal of Biomedical Research Res. (Online), (2010)

119. Koroma J.B, Peterson J, Gbakima A.A, Nylander F.E, Sahr F, SoaresMagalhaes, R.J, Zhang Y, and Hodges M.H. Geographical Distribution of Intestinal Schistosomiasis and Soil-Transmitted Helminthiasis and Preventive Chemotherapy Strategies in Sierra Leone.  PLOS Neglected Tropical Diseases.  (2010).  Vol. 4 Issue 11 891 pp 1-9.

120. Sahr F., Solayide, A.A, Hanson C., Kanty T.V, George T.A. and Harding D., Nasal Carriage of Staphylococcus aureus and Antibiotic Susceptibility Pattern among children in Freetown, Sierra Leone. Sierra Leone Journal of Biomedical Research (SLJBR). (2010). Vol. 2 (1) pp 65-69.

121. Solayide A.A., Gevao F.T., Sahr F., Gevao M.S. Seroprevalence of Human Immunodeficiency and Hepatitis B viruses among patients at a health facility in Freetown, Sierra Leone.  Sierra Leone Journal of Biomedical Research (SLJBR). (2010). Vol. 2 (1) pp 28-31

122. Sahr F, Gevao S.M, Bockarie A., Ibrahim-Sayo E., Sevalie S., Hanciles A. and Gbakima A.A. Treatment of uncomplicated falciparum malaria with Artesunate-Amodiaquine Combined Therapy (ACT) in rural Sierra Leone.  Sierra Leone Journal of Biomedical Research. (2009) Vol. 1 No. 2. Pp 21-26.

123. Sahr F., Kargbo B., Gevao S.M., Gbakima A.A., and Swarray-Deen Knowledge, Perception of risk and attitude of Sierra Leone Military Personnel towards Colleagues with HIV/AIDS.  Sierra Leone Journal of Biomedical Research (2009). Vol. 1 No. 1 pp 38-43

124. Sahr F., Jones J. and Barh S.B. Prevalence of Intestinal Helminth Infection among children under 15 years in selected communities in Monrovia, Liberia.  Sierra Leone Journal of Biomedical Research (2009) Vol. 1, No. 1 pp 28 – 32

125. Sahr F., Jalloh M.I., Kargbo B. and Gbakima A.A. Prevalence of HIV and Other Sexually Transmitted Infections in the Republic of Sierra Leone Armed Forces.  African Journal of Science and Technology (AJST) (2008) Vol. 9, No. 2 pp1-4.

126. Gbakima A.A., Konteh R., Kramer N., Sahr F., Mansaray H., Pessima A., Becker M., Kallon M., Bah Z.J., Spencer A. and Luckay A. Intestinal protozoa and intestinal helminthic infections in Displacement Camps in Sierra Leone.  Africa Journal of Medicine and Medical Sciences (2007) 36 pp 1-9

127. Xun Wang, Sahr F., Ting Xue and Baolin Sun Methylobacterium salsuginis sp. Nov., isolated from Seawater, International Journal of Systematic and Evolutionary Microbiology (2007), 57, pp1699 – 1703.

128. Jolloh A., Gamanga J., Jalloh M., Sahr F., Gbakima A.A. and Willoughby V.R. G6PD. Deficiency Assessment in Freetown, Sierra Leone, reveals further insight into the molecular heterogeneity of G6PD A-(short communication). Journal of Human Genetics (2008) DO1 10.1007/s 10038-008-0294-y

129. Sahr F., Gbakima A.A, Terry B., Willoughby V.R and Bockarie M. Assessment of the therapeutic Efficacy of Chloroquine and Fansidar in the treatment of uncomplicated falciparum Malaria.  Journal of Pure and Applied Aciences. (2004) Vol. 9. Pp89-92.

130. Sahr F., Rogers I., and Willoughby V.R. Immunochromatographic test in the diagnosis of falciparum Malaria inpatients in Freetown, Sierra Leone.  Journal of Pure and Applied Sciences (2004) Vol. 9 pp 93-95.

131. Sahr F., Morgan H.G., Willoughby V.R. and Gbakima A.A. Efficacy of Chloroquine in childhood uncomplicated malaria at Primary Health Care level in Sierra Leone.  Sierra Leone Medical and Dental Journal (2004). Vol. 13 No. 1 pp54-59.

132. Sillah A.S.B, Sahr F. and Kamara C.A – Clinical waste management at Biomedical Laboratories in Freetown, Sierra Leone. Sierra Leone Medical and Dental Journal (2003) Vol. 12 No. 1 pp66-69

133. Gbakima A A , Terry B C, Kortequee S, Dukuley I, Sahr F. High prevalence of bedbugs Cimex hemipterus and Cimex lectularis in camps for internally displace persons in Freetown, Sierra Leone: a pilot humanitarian investigation: West African Journal of Medicine, 2021 (4), 258-271.

134. Thorson A E, Deen G F, Bernstein K T, Liu W J, Yamba F, Habib N, Sahr F. Persistence of Ebola virus in semen among Ebola  virus disease survivors in Sierra Leone A Cohot study of frequency, duration and risk factors.  PLoS Medicine (2021) 18 (2).

135. Willoughby V.R., Sahr F., Russel J.W.B. and Gbakima A.A. The usefulness of Defined Clinical Features in the Diagnosis of HIV/AIDS infection in Sierra Leone.  Cellular and Molecular Biology.  (2001). 47 (7) 1163 – 1167.

136. Sahr F., Willoughby V.R., Gbakima A.A. and Bockarie M.J. Apparent Drug failure following Artesunate treatment in plasmodium falciparum Malaria in Freetown, Sierra Leone.  4 cases reports.  Annals to Tropical Medicine and Parasitology (2001) 95:5, 445-449.

137. Willoughby V.R. and Sahr F. Diabetes admission at Connaught Hospital.  A retrospective study.  Sierra Leone Medical and Dental Association Journal.  (2001) 10(1).pp28-31.

138. Sahr F., Habib Al-Ali and Sillah A.B.S. Prevalence of the four (4) species of Plasmodium in Freetown.  Sierra Leone Medical and Dental Journal. (2001). Vol. 10. Pp20-23

139. Gbakima A.A., Bockarie M.J., Sahr F., Palmer L. and Gooding E. Rapid Assessment of the prevalence and Distribution of Lymphatic filariasis in Sierra Leone.  Annals of Tropical Medicine and Parasitology. (2000) 94 (93) 

140. Terry B., Kanjah F., Sahr F., Kortequees S., Dukulay I. and Gbakima A.A. Sarcoptes Scabeie infectation among children in displacement camp in Sierra Leone.  Journal of Public Health (2000) 115. Pp1-4.

141. Gbakima A A, Kortequee S, Dukulay I, Luckay A, Sahr F. Cryptosporidium and Giardia Infection in Children in Displacement Camps in Sierra Leone. American Journal of Tropical Medicine and Hygiene, (2000) 62 (3: Supp).

142. Gbakima A A, Sahr F, Palmer L, Bockarie M J, Gooding E, Scott A L. Wuchereria Bancrofti Infection in Displacement Camps in Freetown, Sierra Leone. American Journal of Tropical Medicine and Hygiene (1999)

143. Sahr F., Babadi J. and Gbakima A.A. Tuberculosis and the outcome of treatment among Children and Adolescents in Freetown, Sierra Leone.  Sierra Leone Medical and Dental Journal (1998) 9(1): pp1-14.

144. Gbakima A.A, J Pessima and Sahr F. Parasitology and Clinical studies on Wuchereria bancrofti infection in Moyamba District.  African Journal of Health Sciences (1996) 3(2): 37-40.

145. Gbakima A.A. and Sahr F. Filatiasis in the Kaiyamba Chiefdom, Moyamba District Sierra Leone.  An Epidemiological and Clinical study.  Journal of the Society of Public Health (1996). 110: pp169 – 174.

146. Sahr F., Hazra P.K. and Grillo T.A.I. Total and Differential White Cell Count in Healthy Sierra Leoneans.  West African Journal of Medicine.  14(2): 27-31 (1995). Pp105-107.

147. Gbakima A.A. and Sahr F. Intestinal Parasitic Infections among rural farming communities in Eastern Sierra Leone.  African Journal of Medicine and Medical Sciences.  (1995) 24. Pp 195-200.

148. Harkrider J.R., Gbakima A.A., Kandeh J.B. and Sahr F. mermithid (Nematoda: mermithidae) parasitism of Simulium damnosums.l. (Diptera: Simuliidae) in Sierra Leone and the need for vector control.  American Journal of Entomology. (1994) Vol. 28(3) pp421-423.

149. Gbakima A.A., Kandeh J.B. and Sahr F. Transmission of Onchocerca vulvulus in four villages in Gorama Chiefdom, Kono District.  Sierra Leone medical and Dental Journal Vol. 7, No. 1 (1993) pp28-37.